The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation
Open accessAbstract
Anandamide was the first brain metabolite shown to act as a ligand of “central” CB1 cannabinoid receptors. Here we report that the endogenous cannabinoid potently and selectively inhibits the proliferation of human breast cancer cells in vitro . Anandamide dose-dependently inhibited the proliferation of MCF-7 and EFM-19 cells with IC 50 values between 0.5 and 1.5 μM and 83–92% maximal inhibition at 5–10 μM. The proliferation of several other nonmammary tumoral cell lines was not affected by 10 μM anandamide. The anti-proliferative effect of anandamide was not due to toxicity or to apoptosis of cells but was accompanied by a reduction of cells in the S phase of the cell cycle. A stable analogue of anandamide ( R )-methanandamide, another endogenous cannabinoid, 2-arachidonoylglycerol, and the synthetic cannabinoid HU-210 also inhibited EFM-19 cell proliferation, whereas arachidonic acid was much less effective. These cannabimimetic substances displaced the binding of the selective cannabinoid agonist [ 3 H]CP 55,940 to EFM-19 membranes with an order of potency identical to that observed for the inhibition of EFM-19 cell proliferation. Moreover, anandamide cytostatic effect was inhibited by the selective CB1 receptor antagonist SR 141716A. Cell proliferation was arrested by a prolactin mAb and enhanced by exogenous human prolactin, whose mitogenic action was reverted by very low (0.1–0.5 μM) doses of anandamide. Anandamide suppressed the levels of the long form of the prolactin receptor in both EFM-19 and MCF-7 cells, as well as a typical prolactin-induced response, i.e., the expression of the breast cancer cell susceptibility gene brca1 . These data suggest that anandamide blocks human breast cancer cell proliferation through CB1-like receptor-mediated inhibition of endogenous prolactin action at the level of prolactin receptor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi-Carmona, M., Barth, F., Héaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Néliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,757
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,587
Self-citationPharmacology of cannabinoid CB1 and CB2 receptors
Pertwee, R. G. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)82001-3 · Cited by 1,470
Facci, L., Dal Toso, R., Romanello, S., Buriani, A., Skaper, S. D., & Leon, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3376 · Cited by 632
Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl
Somasundaram, K., Zhang, H., Zeng, Y.-X., Houvras, Y., Peng, Y., Zhang, H., Wu, G. S., Licht, J. D., Weber, B. L., & El-Deiry, W. S. (1997) · Nature · doi:10.1038/38291 · Cited by 509
Felder, C. C., Briley, E. M., Axelrod, J., Simpson, J. T., Mackie, K., & Devane, W. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7656 · Cited by 475
Schatz, A. R., Lee, M., Condie, R. B., Pulaski, J. T., & Kaminski, N. E. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.8034 · Cited by 358
(R)-Methanandamide: A Chiral Novel Anandamide Possessing Higher Potency and Metabolic Stability
Abadji, V., Lin, S., Taha, G., Griffin, G., Stevenson, L. A., Pertwee, R. G., & Makriyannis, A. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00038a020 · Cited by 346
Expression of prolactin and its receptor in human lymphoid cells
Pellegrini, I. (1992) · Molecular Endocrinology · doi:10.1210/me.6.7.1023 · Cited by 308
Schmid, P. C., Paria, B. C., Krebsbach, R. J., Schmid, H. H. O., & Dey, S. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4188 · Cited by 264
Prolactin synthesis and secretion by human breast cancer cells.
Ginsburg, E., & Vonderhaar, B. (1995) · PubMed · Cited by 260
Clevenger, C. V., Chang, W. P., Ngo, W., Pasha, T. L., Montone, K. T., & Tomaszewski, J. E. (1995) · PubMed Central · Cited by 252
Rajan, J. V., Wang, M., Marquis, S. T., & Chodosh, L. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13078 · Cited by 219
Inhibitors of arachidonoyl ethanolamide hydrolysis.
Koutek, B., Prestwich, G. D., Howlett, A. C., Chin, S. A., Salehani, D., Akhavan, N., & Deutsch, D. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31599-5 · Cited by 201
Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors.
Lake, K. D., Compton, D. M., Varga, K., Martin, B. R., & Kunos, G. (1997) · PubMed · Cited by 195
Schwarz, H., Blanco, F. J., & Lotz, M. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90152-x · Cited by 180
Weidenfeld, J., Feldman, S., & Mechoulam, R. (1994) · Neuroendocrinology · doi:10.1159/000126646 · Cited by 177
Prolactin Signaling in Mammary Gland Development
Hennighausen, L., Robinson, G. W., Wagner, K.-U., & Liu, X. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7567 · Cited by 172
Further evidence for the presence of cannabinoid CB1 receptors in guinea‐pig small intestine
Pertwee, R. G., Fernando, S. R., Nash, J. E., & Coutts, A. A. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15663.x · Cited by 164
The N-acylation-phosphodiesterase pathway and cell signalling
Schmid, H. H. O., Schmid, P. C., & Natarajan, V. (1996) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(96)02554-6 · Cited by 159
Munro, S. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)81598-7 · Cited by 154
BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells.
Vaughn, J. P., Davis, P. L., Jarboe, M. D., Hüper, G., Evans, A. C., Wiseman, R. W., Berchuck, A., Iglehart, J. D., Futreal, P. A., & Marks, J. R. (1996) · PubMed · Cited by 145
Lee, M., Yang, K. H., & Kaminski, N. E. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12097-1 · Cited by 144
Prolactin Receptor Antagonists That Inhibit the Growth of Breast Cancer Cell Lines
Fuh, G., & Wells, J. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13133 · Cited by 128
Search for endogenous ligands of the cannabinoid receptor
Mechoulam, R., Hanuš, L., & Martin, B. R. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90197-x · Cited by 127
Bisogno, T., Katayama, K., Melck, D. J., Ueda, N., PETROCELLIS, L. D., Yamamoto, S., & Marzo, V. D. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2540634.x · Cited by 95
Self-citationRequirement for prolactin during cell cycle regulated gene expression in cloned T-lymphocytes
Clevenger, C. V., Sillman, A. L., Hanley-Hyde, J., & Prystowsky, M. B. (1992) · Endocrinology · doi:10.1210/en.130.6.3216 · Cited by 89
Wenger, T., Jamali, K. A., Juanéda, C., Léonardelli, J., & Tramu, G. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7222 · Cited by 85
FemándeZ-Ruiz, J. J., Muñoz, R. M., Romero, J., Villanúa, M. A., Makriyannis, A., & Ramos, J. A. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00168-8 · Cited by 83
Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits
Pate, D. W., Järvinen, K., Urtti, A., Jarho, P., & Järvinen, T. (1995) · Current Eye Research · doi:10.3109/02713689508995801 · Cited by 72
Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cells
Cabral, G. A., TONEY, D. M., Fischer‐Stenger, K., Harrison, M. P., & Marciano‐Cabral, F. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00190-h · Cited by 69
Failure of cannabinoid compounds to stimulate estrogen receptors
Ruh, M. F., Taylor, J. A., Howlett, A. C., & Welshons, W. V. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00659-4 · Cited by 44
Simon, W. E., PAHNKE, V. G., & Hölzel, F. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-6-1243 · Cited by 26
Arachidonate—Phospholipid Remodeling and Cell Proliferation
Chilton, F. H., Surette, M. E., & Winkler, J. D. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-0179-8_28 · Cited by 19
Cited by
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
“…tyrosine kinase activity (Casanova et al., 2003; Mimeault et al., 2003), and a decrease in the activity and/or expression of nerve growth factor or vascular endothelial growth factor tyrosine kinase receptors and prolactin (De Petrocellis et al., 1998; Melck et al., 2000; Portella et al., 2003).”
BackgroundPharmacokinetics and Pharmacodynamics of Cannabinoids
Grotenhermen, F. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342040-00003 · Cited by 1,511
The endocannabinoid system and its therapeutic exploitation
Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090
Self-citationCannabinoid-based drugs as anti-inflammatory therapeutics
Klein, T. W. (2005) · Nature Reviews Immunology · doi:10.1038/nri1602 · Cited by 728
Metadata
- Authors
- De Petrocellis, L., Melck, D., Palmisano, A., Bisogno, T., Laezza, C., Bifulco, M., & Di Marzo, V.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1998-07-07
- Volume
- 95
- Issue
- 14
- Pages
- 8375-8380
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2144898517
- Cited by
- 413
- References
- 38
- FWCI
- 12.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.